| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.099 | 0.005 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.098 | 0.005 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.005 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.005 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.005 |